South Africa Diabetes Clinical Trials Market Size & Outlook
Related Markets
South Africa diabetes clinical trials market highlights
- The South Africa diabetes clinical trials market generated a revenue of USD 21.1 million in 2025 and is expected to reach USD 40.0 million by 2033.
- The South Africa market is expected to grow at a CAGR of 8.6% from 2026 to 2033.
- In terms of segment, phase iii was the largest revenue generating phase in 2025.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Diabetes clinical trials market data book summary
| Market revenue in 2025 | USD 21.1 million |
| Market revenue in 2033 | USD 40.0 million |
| Growth rate | 8.6% (CAGR from 2026 to 2033) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.4% of the global diabetes clinical trials market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa diabetes clinical trials market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 12.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Clinical Trials Market Scope
Diabetes Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Telix Pharmaceuticals | View profile | 251-500 | Melbourne, Victoria, Australia, Oceania | http://www.telixpharma.com |
| Merck Sharp & Dohme Federal Credit Union | View profile | 51-100 | Chalfont, Pennsylvania, United States, North America | https://www.msdfcu.org |
| Parexel International Corporation | View profile | - | - | - |
| Novotech | View profile | 1001-5000 | Sydney, New South Wales, Australia, Oceania | http://www.novotech-cro.com/ |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
South Africa diabetes clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 56.87% in 2025. Horizon Databook has segmented the South Africa diabetes clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to South Africa diabetes clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa diabetes clinical trials market databook
-
Our clientele includes a mix of diabetes clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa diabetes clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into South Africa diabetes clinical trials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa diabetes clinical trials market size, by phase, 2021-2033 (US$M)
South Africa Diabetes Clinical Trials Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
